by Shirley Amy on August 28, 2019
In order to address patient safety, general well-being, and successful outcomes, a joint statement has just been released by the AANA (American Association of Nurse Anesthetists) and the APNA (American Psychiatric Nurses Association).
This statement highlights the crucial part that CRNAs and PMH nurses play in the implementation of ketamine infusion therapy for mental health disorders. In addition to this, it also supports providers with much needed resources. Further, by investing in the standards and scope of practice of both CRNAs and PMH nurses, this collaborate ensures that ketamine infusion therapy is conducted in an effective and safe manner.
More on Ketamine Infusion Therapy
This form of therapy is increasingly being used for mental health issues. These include: post-traumatic stress disorder, treatment resistant depression, bipolar disorder, and major depressive disorder. CRNAs receive in depth training in ketamine infusion therapy, so that they can treat individuals with medication resistant and chronic mental health diseases. Moreover, they collaborate with PMH nurses and other professionals who specialize in the treatment, diagnosis, and assessment of psychiatric mental health disorders.
Taking a Positive Perspective
The President of APNA, Gail Stern, RN, MSN, stated that: “Psychiatric-mental health nurses play a vital role in the assessment, referral to treatment, and ongoing monitoring of patients receiving ketamine infusion therapy for psychiatric disorders. Through their nursing expertise in psychiatric-mental health, they ensure that patients who receive ketamine infusion therapy achieve the best possible mental health outcomes in a safe and therapeutic manner that promotes their long-term recovery”.
Further, the President of AANA, Kate Jansky, noted that: “The use of ketamine infusion therapy to help treat psychiatric disorders is a godsend for many patients, particularly for those patients where standard treatment has not worked. CRNAs and PMH Nurses complement each other’s unique expertise in the delivery of ketamine infusion therapy with a shared focus on improving patient safety and outcomes. We are grateful for the opportunity to work closely with our psychiatric-mental health nursing colleagues to bring comfort and quality of life to patients in need of this new therapeutic treatment”.
In addition, Nicholas Croce Jr., MS., APNA’s Executive Director, remarked that: “APNA is proud to partner with AANA to provide a joint statement that will help guide nursing professionals as they provide this therapy. Providing evidence-based resources and promoting collaboration amongst professionals will only serve to enrich the safe and effective care patients receive”.
And the CEO of AANA, Randall Moore, DNP, MBA, made the point that: “It has been an honor and privilege to work in partnership with the APNA to develop this important position statement defining the roles and responsibilities of these exceptional nursing professionals in the administration of this new and effective therapeutic treatment”.
More About the AANA
This renowned association, which is based in Washington, D.C., was founded back in 1931. It represents close to 54,000 Certified Registered Nurse Anesthetists and registered students across America.
More About the APNA
This well known countrywide professional membership organization is dedicated to the treatment and care of individuals with psychiatric illness; as well as the practice of psychiatric-mental health nursing.